Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Dolan

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1989
Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanineM E Dolan, G L Larkin, H F English, et al.
Clinical Pharmacology and Therapeutics|August 23, 2012
Clinical translation of cell-based pharmacogenomic discoveryN J Cox, E R Gamazon, H E Wheeler, et al.
Biochemical Pharmacology|October 12, 1995
Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosoureaA E Pegg, K Swenn, M Y Chae, et al.
Journal of Medicinal Chemistry|November 13, 1992
Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferaseR C Moschel, M G McDougall, M E Dolan, et al.
Carcinogenesis|December 1, 1985
Depletion of O6-methylguanine-DNA-methyltransferase in human fibroblasts increases the mutagenic response to N-methyl-N'-nitro-N-nitrosoguanidineJ Domoradzki, A E Pegg, M E Dolan, et al.
Cancer Research|July 1, 1991
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agentsM E Dolan, R B Mitchell, C Mummert, et al.
Carcinogenesis|December 1, 1984
Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidineJ Domoradzki, A E Pegg, M E Dolan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaG M Felker, H S Friedman, M E Dolan, et al.
Molecular Cancer Therapeutics|December 7, 2002
Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cellsY Cai, S M Ludeman, L R Wilson, et al.
Cancer Communications|January 1, 1990
Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosoureaM E Dolan, L Stine, R B Mitchell, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1989
Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanineM E Dolan, G L Larkin, H F English, et al.
Clinical Pharmacology and Therapeutics|August 23, 2012
Clinical translation of cell-based pharmacogenomic discoveryN J Cox, E R Gamazon, H E Wheeler, et al.
Biochemical Pharmacology|October 12, 1995
Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosoureaA E Pegg, K Swenn, M Y Chae, et al.
Journal of Medicinal Chemistry|November 13, 1992
Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferaseR C Moschel, M G McDougall, M E Dolan, et al.
Carcinogenesis|December 1, 1985
Depletion of O6-methylguanine-DNA-methyltransferase in human fibroblasts increases the mutagenic response to N-methyl-N'-nitro-N-nitrosoguanidineJ Domoradzki, A E Pegg, M E Dolan, et al.
Cancer Research|July 1, 1991
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agentsM E Dolan, R B Mitchell, C Mummert, et al.
Carcinogenesis|December 1, 1984
Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidineJ Domoradzki, A E Pegg, M E Dolan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaG M Felker, H S Friedman, M E Dolan, et al.
Molecular Cancer Therapeutics|December 7, 2002
Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cellsY Cai, S M Ludeman, L R Wilson, et al.
Cancer Communications|January 1, 1990
Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosoureaM E Dolan, L Stine, R B Mitchell, et al.
Pageof 12